Population pharmacokinetic analysis for tisotumab vedotin in patients with locally advanced and/or metastatic solid tumors
Abstract Tisotumab vedotin is an investigational antibody-drug conjugate (ADC) for treatment of solid tumors expressing tissue factor with accelerated approval from the US Food and Drug Administration for treatment of recurrent or metastatic cervical cancer with disease progression during or after c...
Saved in:
Main Authors: | , , , , , , |
---|---|
格式: | 图书 |
出版: |
Wiley,
2022-10-01T00:00:00Z.
|
主题: | |
在线阅读: | Connect to this object online. |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
因特网
Connect to this object online.3rd Floor Main Library
索引号: |
A1234.567 |
---|---|
复印件 1 | 可用 |